Daily funding & deals roundup: 6 stories curated October 23, 2026. Lead: Ultraviolette Introduces X-47 Venom With 12 kW DC Fast Charging.

The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Ultraviolette Introduces X-47 Venom With 12 kW DC Fast Charging.
Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a majority stake in Aurion Biotech, a startup developing a corneal cell therapy. The post Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition appeared first on MedCity News.
Follow the full firehose on the HTC Wire, refreshed automatically every day.